|
1 |
Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study
Glemser, Philip. - Freiburg : Universität, 2024
|
|
|
|
2 |
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
Dührsen, Ulrich. - Aachen : Universitätsbibliothek der RWTH Aachen, 2024
|
|
|
3 |
Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
Enthalten in European journal of nuclear medicine and molecular imaging 14.3.2016: 1-7
|
|
|
|
4 |
Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer
Enthalten in Scientific reports Bd. 8, 12.11.2018, Nr. 1, date:12.2018: 1-8
|
|
|
|
5 |
Enhancing the diagnostic capacity of [18F]PSMA-1007 PET/MRI in primary prostate cancer staging with artificial intelligence and semi-quantitative DCE: an exploratory study
Enthalten in EJNMMI reports Bd. 8, 8.11.2024, Nr. 1, date:12.2024: 1-12
|
|
|
|
6 |
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Enthalten in European journal of nuclear medicine and molecular imaging Bd. 42, 20.11.2014, Nr. 2, date:2.2015: 197-209
|
|
Administration
